MMI develops and supplies a robotic-assisted microsurgery system and Robotic Suture technology used in clinical procedures.
MMI is an Italy/US surgical-robotics maker whose Symani system does robotic microsurgery (tissue transfer, lymphatic repair), now in a US launch campaign, having enrolled its first patient in the landmark US PRECISE clinical study in November 2025. It raised a $110M Series C in February 2024. Revenue is estimated at <25m (private).
4 signals name MMI Medical Microinstruments. Members see all of them, filtered by topic, source and date.
5 facts on file. Members see all of them with the source link.
Traction: deployment, production, commercials, progress. Capability: technology, positioning, firepower, leverage.
MMI develops and supplies a robotic-assisted microsurgery system and Robotic Suture technology used in clinical procedures. MMI is an Italy/US surgical-robotics maker whose Symani system does robotic microsurgery (tissue transfer, lymphatic repair), now in a US launch campaign, having enrolled its first patient in the landmark US PRECISE clinical study in November 2025. It raised a $110M Series C in February 2024. Revenue is estimated at <25m (private).
MMI Medical Microinstruments is on the Robotics watchlist list of Frontier Tech Intelligence with a score of 58 out of 100, below the Top 100.
MMI Medical Microinstruments is based in Pisa, Tuscany, Italy.
Subscribers see the full file, every signal, the live ranking and the questions the signals answer: where money moved, who controls the layer, where supply is constrained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →